Correct, what I was alluding to is that the licensing company would eventually absorb PAA rather than continue paying royalties. Particularly as there is the possibility of other neurological applications.
100 million per year in royalties would probably result in a conservative Cap of 500 - 1 billion dollars. Either way we win, we just need MPL to continue kicking goals.
Exciting times.
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow), page-42
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.015(7.89%) |
Mkt cap ! $99.76M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $129.6K | 653.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 119947 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 119150 | 7 |
View Market Depth
| Last trade - 15.59pm 09/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |